135 related articles for article (PubMed ID: 4687777)
1. The inhibition of tissue plasminogen activator and urokinase-induced fibrinolysis by some natural proteinase inhibitors and by plasma and serum from normal and pregnant subjects.
Thorsen S
Scand J Clin Lab Invest; 1973 Jan; 31(1):51-9. PubMed ID: 4687777
[No Abstract] [Full Text] [Related]
2. The effects of some synthetic compounds on in vitro fibrinolytic activity measured by different methods and the relevance to activity in vivo.
Baillie AJ; Sim AK
Thromb Diath Haemorrh; 1972 Dec; 28(3):351-8. PubMed ID: 4265316
[No Abstract] [Full Text] [Related]
3. [Research on the inhibitors of fibrinolysis: the methods of measuring antistreptokinase, antiplasmin and antitrypsin].
GIACOMAZZI G
Haematol Lat; 1961; 4():255-71. PubMed ID: 13898268
[No Abstract] [Full Text] [Related]
4. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
Veremeenko KN; Kizim AI
Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
[TBL] [Abstract][Full Text] [Related]
5. [On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes].
Frick G; Frick U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):389-403. PubMed ID: 4168276
[No Abstract] [Full Text] [Related]
6. THE EUGLOBULIN METHOD FOR ESTIMATION OF FIBRINOLYTIC ACTIVITY IN UROKINASE-ACTIVATED PLASMA, AND THE INFLUENCE OF TRASYLOL.
BLIX S
Scand J Clin Lab Invest; 1964; 16():198-200. PubMed ID: 14161857
[No Abstract] [Full Text] [Related]
7. [Studies on the effect of urokinase on the fibrinolytic activity of the blood].
ANDREENKO GV; STRUKOVA SM
Biokhimiia; 1962; 27():327-9. PubMed ID: 13861411
[No Abstract] [Full Text] [Related]
8. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase].
Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K
Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of fibrinolysis. A comparative thrombelastographic study.
Egeblad K
Scand J Clin Lab Invest Suppl; 1967; 98():1-69. PubMed ID: 4228724
[No Abstract] [Full Text] [Related]
10. Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
Thorsen S
Dan Med Bull; 1977 Oct; 24(5):189-206. PubMed ID: 908205
[No Abstract] [Full Text] [Related]
11. Comparative activities of amino acid and polypeptide inhibitors on natural and synthetic substrates.
Skoza L; Tse AO; Semar M; Johnson AJ
Ann N Y Acad Sci; 1968 Jun; 146(2):659-72. PubMed ID: 4239440
[No Abstract] [Full Text] [Related]
12. Effects of Poloxamer 188 on fibrin network structure, whole blood clot premeability and fibrinolysis.
van Gelder JM; Nair CH; Dhall DP
Thromb Res; 1993 Sep; 71(5):361-76. PubMed ID: 8236163
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of fibrinolytic activity in human, rat, rabbit, and dog blood.
Hedlin AM; Monkhouse FC; Milojevic SM
Can J Physiol Pharmacol; 1972 Jan; 50(1):11-6. PubMed ID: 4257760
[No Abstract] [Full Text] [Related]
14. ON THE COMBINED ADMINISTRATION OF STREPTOKINASE AND PANCREATIC TRYPSIN INHIBITOR.
VERSTRAETE M; VERMYLEN J; VERMYLEN C; DEVREKER RA
Thromb Diath Haemorrh; 1964 Dec; 12():391-5. PubMed ID: 14254698
[No Abstract] [Full Text] [Related]
15. SOME CONSIDERATIONS IN THE SYSTEMIC USE OF FIBRINOLYTIC AGENT.
COON WW
Mich Med; 1964 Jul; 63():488-90. PubMed ID: 14182774
[No Abstract] [Full Text] [Related]
16. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
[TBL] [Abstract][Full Text] [Related]
17. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
Gurewich V; Pannell R
Thromb Haemost; 1987 Jun; 57(3):372-3. PubMed ID: 3116707
[No Abstract] [Full Text] [Related]
18. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of fibrinolysis.
Haire WD
Chest; 1992 Apr; 101(4 Suppl):91S-97S. PubMed ID: 1555484
[TBL] [Abstract][Full Text] [Related]
20. Impairment of fibrinolysis by streptokinase, urokinase and recombinant tissue-type plasminogen activator in the presence of radiographic contrast agents.
Dehmer GJ; Gresalfi N; Daly D; Oberhardt B; Tate DA
J Am Coll Cardiol; 1995 Apr; 25(5):1069-75. PubMed ID: 7897118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
